NASDAQ
Arno Therapeutics, Inc. (ARNI) has a eps (diluted) of $-0.57 as of Thursday, December 31, 2015. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.